-
1
-
-
0037772255
-
The sirolimus-eluting stent:a review of its use in the treatment of coronary artery disease
-
Mckeage K, Murdoch D, Goa KL. The sirolimus-eluting stent:a review of its use in the treatment of coronary artery disease. Am J Cardiovasc Drugs. 2003;3:211-230.
-
(2003)
Am J Cardiovasc Drugs
, vol.3
, pp. 211-230
-
-
Mckeage, K.1
Murdoch, D.2
Goa, K.L.3
-
2
-
-
10744222911
-
Analysis of 1-year clinical outcomes in the SIRIUS trial: A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis
-
Holmes DR Jr, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation. 2004;109:634-640.
-
(2004)
Circulation
, vol.109
, pp. 634-640
-
-
Holmes Jr, D.R.1
Leon, M.B.2
Moses, J.W.3
-
3
-
-
0141863201
-
Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomized controlled trial (E-SIRIUS)
-
Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS). Lancet. 2003;362:1093-1099.
-
(2003)
Lancet
, vol.362
, pp. 1093-1099
-
-
Schofer, J.1
Schluter, M.2
Gershlick, A.H.3
-
4
-
-
1542708491
-
The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries(C-SIRIUS)
-
Schampaert E, Cohen EA, Schluter M, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries(C-SIRIUS). J Am Coll Cardiol. 2004;43:1110-1115.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 1110-1115
-
-
Schampaert, E.1
Cohen, E.A.2
Schluter, M.3
-
5
-
-
0042388295
-
Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
-
TAXUS-IV Study Group
-
TAXUS-IV Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108:788-794.
-
(2003)
Circulation
, vol.108
, pp. 788-794
-
-
-
6
-
-
9144249927
-
A polymer-based,paclitaxel-eluting stent in patients with coronary artery disease
-
Stone GW, Ellis SG, Cox DA, et al. A polymer-based,paclitaxel-eluting stent in patients with coronary artery disease. N Engl Med. 2004;350:221-231.
-
(2004)
N Engl Med
, vol.350
, pp. 221-231
-
-
Stone, G.W.1
Ellis, S.G.2
Cox, D.A.3
-
7
-
-
0031277778
-
Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets
-
Sheu JR, Kan YC, Hung WC, et al. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets. Thromb Res. 1997;88:259-270.
-
(1997)
Thromb Res
, vol.88
, pp. 259-270
-
-
Sheu, J.R.1
Kan, Y.C.2
Hung, W.C.3
-
8
-
-
0028332635
-
Antiplatelet activity of tetramethylpyrazine
-
Liu SY, Sylvester DM. Antiplatelet activity of tetramethylpyrazine. Thromb Res. 1994;75:51-62.
-
(1994)
Thromb Res
, vol.75
, pp. 51-62
-
-
Liu, S.Y.1
Sylvester, D.M.2
-
9
-
-
0034647592
-
The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase
-
Sheu JR, Kan YC, Hung WC, et al. The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase. Life Sci. 2000;67:937-947.
-
(2000)
Life Sci
, vol.67
, pp. 937-947
-
-
Sheu, J.R.1
Kan, Y.C.2
Hung, W.C.3
-
11
-
-
0032106095
-
Effects of tetramethylpyrazine and radix salviae miltiorrhizae on collagen synthesis and proliferation of cardiac fibroblasts
-
Song D, Su H, Wu M. Effects of tetramethylpyrazine and radix salviae miltiorrhizae on collagen synthesis and proliferation of cardiac fibroblasts. Chinese Journal of Integrated Traditional and Western Medicine. 1998;18:423-425.
-
(1998)
Chinese Journal of Integrated Traditional and Western Medicine
, vol.18
, pp. 423-425
-
-
Song, D.1
Su, H.2
Wu, M.3
-
12
-
-
0030112641
-
The effect of ligustrazine and 764-3 on type I and type III collagen mRNA expression in fibroblasts
-
Yan Y, Chen X, Wu K, et al. The effect of ligustrazine and 764-3 on type I and type III collagen mRNA expression in fibroblasts. Acta Academiae Medicinae Sinicae. 1996;18:126-128.
-
(1996)
Acta Academiae Medicinae Sinicae
, vol.18
, pp. 126-128
-
-
Yan, Y.1
Chen, X.2
Wu, K.3
-
13
-
-
0032705193
-
Inhibitory effect of ligustrazine on proliferation of rabbit vascular smooth muscle cells after arterial injury
-
Li S, Wang JH, Chen SL. Inhibitory effect of ligustrazine on proliferation of rabbit vascular smooth muscle cells after arterial injury. Zhongguo Yao Li Xue Bao. 1999;20:917-922.
-
(1999)
Zhongguo Yao Li Xue Bao
, vol.20
, pp. 917-922
-
-
Li, S.1
Wang, J.H.2
Chen, S.L.3
-
14
-
-
0034568030
-
Experimental study on the effect of ligustrazine in the prevention of intimal proliferation of deendothelial artery
-
Zhou X, Lu Z, Zhao H, et al. Experimental study on the effect of ligustrazine in the prevention of intimal proliferation of deendothelial artery. J Tongji Med Univ. 2000;20:205-207.
-
(2000)
J Tongji Med Univ
, vol.20
, pp. 205-207
-
-
Zhou, X.1
Lu, Z.2
Zhao, H.3
-
15
-
-
0026515530
-
Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model
-
Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol. 1992;19:267-274.
-
(1992)
J Am Coll Cardiol
, vol.19
, pp. 267-274
-
-
Schwartz, R.S.1
Huber, K.C.2
Murphy, J.G.3
|